Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $310,193 (100.0% shares, 0.0% debt)

Holdings (19)

— Medivation, Inc. 81.0%

Value ($000) $251,117 Shares 2,198,919 Est. Cost $49.20 Unrealized —

— Synthetic Biologics Inc. 3.1%

Value ($000) $9,692 Shares 3,400,816 Est. Cost $1.48 Unrealized —

— Ampio Pharmaceuticals Inc. 2.6%

Value ($000) $8,098 Shares 3,388,322 Est. Cost $6.03 Unrealized —

— Alcobra Ltd 2.4%

Value ($000) $7,294 Shares 1,115,315 Est. Cost $7.08 Unrealized —

— Abeona Therapeutics Inc 2.2%

Value ($000) $6,880 Shares 1,359,767 Est. Cost $5.06 Unrealized —

— Advaxis Inc. 1.8%

Value ($000) $5,591 Shares 275,000 Est. Cost $20.33 Unrealized —

— Corbus Pharmaceuticals HLDGS 1.7%

Value ($000) $5,390 Shares 1,750,000 Est. Cost $3.08 Unrealized —

— Newlink Genetics Corp 1.5%

Value ($000) $4,535 Shares 102,437 Est. Cost $27.98 Unrealized —

— Bio Blast Pharma Ltd 0.8%

Value ($000) $2,330 Shares 338,110 Est. Cost $7.27 Unrealized —

— Keryx Biopharmaceuticals Inc. 0.6%

Value ($000) $1,996 Shares 200,000 Est. Cost $10.21 Unrealized —

— Caladrius Biosciences Inc 0.6%

Value ($000) $1,870 Shares 1,000,000 Est. Cost $1.87 Unrealized —

— Advaxis Inc. 0.6%

Value ($000) $1,749 Shares 112,500 Est. Cost $15.55 Unrealized —

ALDX Aldeyra Therapeutics Inc 0.3%

Value ($000) $1,054 Shares 135,800 Est. Cost $10.20 Unrealized -15.5%

— Lion Biotechnologies Inc 0.3%

Value ($000) $890 Shares 97,100 Est. Cost $12.11 Unrealized —

— Galmed Pharmaceuticals Ltd 0.2%

Value ($000) $654 Shares 65,000 Est. Cost $11.48 Unrealized —

— OHR Pharmaceutical Inc 0.2%

Value ($000) $515 Shares 205,000 Est. Cost $2.54 Unrealized —

— Evoke Pharma Inc 0.1%

Value ($000) $291 Shares 55,660 Est. Cost $7.00 Unrealized —

— Zosano Pharma Corp 0.0%

Value ($000) $145 Shares 20,000 Est. Cost $10.10 Unrealized —

— Aptose Biosciences Inc 0.0%

Value ($000) $102 Shares 20,000 Est. Cost $5.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,198,919	$251,117	81.0%	$49.20	—	COM	58501N101
—	Synthetic Biologics Inc.	3,400,816	$9,692	3.1%	$1.48	—	COM	87164U102
—	Ampio Pharmaceuticals Inc.	3,388,322	$8,098	2.6%	$6.03	—	COM	03209T109
—	Alcobra Ltd	1,115,315	$7,294	2.4%	$7.08	—	SHS	M2239P109
—	Abeona Therapeutics Inc	1,359,767	$6,880	2.2%	$5.06	—	COM	00289Y107
—	Advaxis Inc.	275,000	$5,591	1.8%	$20.33	—	COM NEW	7624208
—	Corbus Pharmaceuticals HLDGS	1,750,000	$5,390	1.7%	$3.08	—	COM	21833P103
—	Newlink Genetics Corp	102,437	$4,535	1.5%	$27.98	—	COM	651511107
—	Bio Blast Pharma Ltd	338,110	$2,330	0.8%	$7.27	—	SHS	M20156101
—	Keryx Biopharmaceuticals Inc.	200,000	$1,996	0.6%	$10.21	—	COM	492515101
—	Caladrius Biosciences Inc	1,000,000	$1,870	0.6%	$1.87	—	COM	128058104
—	Advaxis Inc.	112,500	$1,749	0.6%	$15.55	—	W EXP 07/15/201	7624117
ALDX	Aldeyra Therapeutics Inc	135,800	$1,054	0.3%	$10.20	-15.5%	COM	01438T106
—	Lion Biotechnologies Inc	97,100	$890	0.3%	$12.11	—	COM	53619R102
—	Galmed Pharmaceuticals Ltd	65,000	$654	0.2%	$11.48	—	SHS	M47238106
—	OHR Pharmaceutical Inc	205,000	$515	0.2%	$2.54	—	COM NEW	67778H200
—	Evoke Pharma Inc	55,660	$291	0.1%	$7.00	—	COM	30049G104
—	Zosano Pharma Corp	20,000	$145	0.0%	$10.10	—	COM	98979H103
—	Aptose Biosciences Inc	20,000	$102	0.0%	$5.40	—	COM NEW	03835T200